Skip to main content
Top
Published in: Pediatric Radiology 7/2011

01-07-2011 | Review

Functional imaging of infection: conventional nuclear medicine agents and the expanding role of 18-F-FDG PET

Author: Marguerite T. Parisi

Published in: Pediatric Radiology | Issue 7/2011

Login to get access

Abstract

A growing body of literature suggests that 18-fluorine fluorodeoxyglucose positron emission tomography (18F-FDG PET), particularly when combined with CT, is a useful tool for the detection of infectious and inflammatory disease processes. This article will briefly review the data to date on the use of FDG PET in diagnosing musculoskeletal infections and fever of unknown origin, comparing it to conventional scintigraphic techniques in both adults and, when available, in children.
Literature
1.
go back to reference Gainey MA, Siegal JA, Smergel EM et al (1988) Indium-111 labeled white blood cells: dosimetry in children. J Nucl Med 29:689–694PubMed Gainey MA, Siegal JA, Smergel EM et al (1988) Indium-111 labeled white blood cells: dosimetry in children. J Nucl Med 29:689–694PubMed
2.
go back to reference Dumarey N, Egrise D, Blocker D et al (2006) Imaging infection with 18 F-FDG-labeled leukocyte PET/CT: initial experience in 21 patients. J Nucl Med 47:625–632PubMed Dumarey N, Egrise D, Blocker D et al (2006) Imaging infection with 18 F-FDG-labeled leukocyte PET/CT: initial experience in 21 patients. J Nucl Med 47:625–632PubMed
3.
go back to reference Petruzzi N, Shanthly N, Thakur M et al (2009) Recent trends in soft tissue infection imaging. Semin Nucl Med 39:115–123PubMedCrossRef Petruzzi N, Shanthly N, Thakur M et al (2009) Recent trends in soft tissue infection imaging. Semin Nucl Med 39:115–123PubMedCrossRef
4.
go back to reference Zhuang H, Alavi A (2002) 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med 32:47–59PubMedCrossRef Zhuang H, Alavi A (2002) 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med 32:47–59PubMedCrossRef
5.
go back to reference Basu S, Chryssikos BA, Moghadam-Kia S et al (2009) Positron emission tomography as a diagnostic tool in infection: present role and future possibilities. Semin Nucl Med 39:36–51PubMedCrossRef Basu S, Chryssikos BA, Moghadam-Kia S et al (2009) Positron emission tomography as a diagnostic tool in infection: present role and future possibilities. Semin Nucl Med 39:36–51PubMedCrossRef
6.
go back to reference Stumpke KD, Dazzi H, Schaffner A et al (2000) Infection imaging using whole-body FDG-PET. Eur J Nucl Med 27:822–832CrossRef Stumpke KD, Dazzi H, Schaffner A et al (2000) Infection imaging using whole-body FDG-PET. Eur J Nucl Med 27:822–832CrossRef
7.
go back to reference Chacko TK, Zhuang H, Nakhoda KZ (2003) Applications of fluorodeoxyglucose positron emission tomography in the diagnosis of infection. Nucl Med Commun 24:615–624PubMedCrossRef Chacko TK, Zhuang H, Nakhoda KZ (2003) Applications of fluorodeoxyglucose positron emission tomography in the diagnosis of infection. Nucl Med Commun 24:615–624PubMedCrossRef
8.
go back to reference Love C, Tomas MB, Tronco GG et al (2005) FDG PET of infection and inflammation. Radiographics 25:1357–1368PubMedCrossRef Love C, Tomas MB, Tronco GG et al (2005) FDG PET of infection and inflammation. Radiographics 25:1357–1368PubMedCrossRef
9.
go back to reference Glaudemans AWJM, Signore A (2010) FDG-PET/CT in infections: the imaging method of choice? Eur J Nucl Med Mol Imaging 37:1986–1991PubMedCrossRef Glaudemans AWJM, Signore A (2010) FDG-PET/CT in infections: the imaging method of choice? Eur J Nucl Med Mol Imaging 37:1986–1991PubMedCrossRef
10.
go back to reference Stroebel K, Stumpe KDM (2007) PET/CT in musculoskeletal infection. Semin Musculoskelet Radiol 11:353–364CrossRef Stroebel K, Stumpe KDM (2007) PET/CT in musculoskeletal infection. Semin Musculoskelet Radiol 11:353–364CrossRef
11.
go back to reference Depas G, Decortis T, Francotte N et al (2007) F-18 FDG PET in infectious disease in children. Clin Nucl Med 32:593–598PubMedCrossRef Depas G, Decortis T, Francotte N et al (2007) F-18 FDG PET in infectious disease in children. Clin Nucl Med 32:593–598PubMedCrossRef
12.
go back to reference Skehan SJ, Issenman R, Mertaugh J et al (1999) 18 F-fluorodeoxyglucose positron tomography in diagnosis of paediatric inflammatory bowel disease. Lancet 354:836–837PubMed Skehan SJ, Issenman R, Mertaugh J et al (1999) 18 F-fluorodeoxyglucose positron tomography in diagnosis of paediatric inflammatory bowel disease. Lancet 354:836–837PubMed
13.
go back to reference Lemberg DA, Issenman RM, Cawdron R et al (2005) Positron emission tomography in the investigation of pediatric inflammatory bowel disease. Inflamm Bowel Dis 11:733–738PubMedCrossRef Lemberg DA, Issenman RM, Cawdron R et al (2005) Positron emission tomography in the investigation of pediatric inflammatory bowel disease. Inflamm Bowel Dis 11:733–738PubMedCrossRef
14.
go back to reference Loffler M, Weckesser M, Franzius C et al (2006) High diagnostic value of 18 F-FDG-PET in pediatric patients with chronic inflammatory bowel disease. Ann NY Acad Sci 1072:379–385PubMedCrossRef Loffler M, Weckesser M, Franzius C et al (2006) High diagnostic value of 18 F-FDG-PET in pediatric patients with chronic inflammatory bowel disease. Ann NY Acad Sci 1072:379–385PubMedCrossRef
15.
go back to reference Gungor T, Engle-Bicik I, Eich G et al (2001) Diagnostic and therapeutic impact of whole body positron emission tomography using fluorine-18-fluoro-2-deoxy-D-glucose in children with chronic granulomatous disease. Arch Dis Child 85:341–345PubMedCrossRef Gungor T, Engle-Bicik I, Eich G et al (2001) Diagnostic and therapeutic impact of whole body positron emission tomography using fluorine-18-fluoro-2-deoxy-D-glucose in children with chronic granulomatous disease. Arch Dis Child 85:341–345PubMedCrossRef
16.
go back to reference Simons KS, Pickkers P, Bleeker-Rovers CP et al (2010) F-18 fluorodeoxyglucose positron emission tomography combined with CT in critically ill patients with suspected infection. Intensive Care Med 36:504–511PubMedCrossRef Simons KS, Pickkers P, Bleeker-Rovers CP et al (2010) F-18 fluorodeoxyglucose positron emission tomography combined with CT in critically ill patients with suspected infection. Intensive Care Med 36:504–511PubMedCrossRef
17.
go back to reference Jasper N, Dabritz J, Frosch M et al (2010) Diagnostic value of [18-F]-FDG PET/CT in children with unknown origin or unexplained signs of inflammation. Eur J Nucl Med Mol Imaging 37:136–145PubMedCrossRef Jasper N, Dabritz J, Frosch M et al (2010) Diagnostic value of [18-F]-FDG PET/CT in children with unknown origin or unexplained signs of inflammation. Eur J Nucl Med Mol Imaging 37:136–145PubMedCrossRef
18.
go back to reference Sturm E, Rings EHHM, Scholvinck E et al (2006) Fluorodeoxyglucose positron emission tomography contributes to management of pediatric liver transplantation candidates with fever of unknown origin. Liver Transplant 12:1698–1704CrossRef Sturm E, Rings EHHM, Scholvinck E et al (2006) Fluorodeoxyglucose positron emission tomography contributes to management of pediatric liver transplantation candidates with fever of unknown origin. Liver Transplant 12:1698–1704CrossRef
19.
go back to reference Gallagher BM, Fowler JS, Guttersin NF et al (1987) Metabolic trapping as a principle of radiopharmaceutical design: some factors responsible for the biodistribution of [18F]2-deoxy-2 fluoro-D-glucose. J Nucl Med 19:1154–1161 Gallagher BM, Fowler JS, Guttersin NF et al (1987) Metabolic trapping as a principle of radiopharmaceutical design: some factors responsible for the biodistribution of [18F]2-deoxy-2 fluoro-D-glucose. J Nucl Med 19:1154–1161
20.
go back to reference Fu Y, Maianu L, Melbert BR et al (2004) Facilitative glucose transporter gene expression in human lymphocytes, monocytes and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. Blood Cells Mol Dis 32(1):182-190CrossRef Fu Y, Maianu L, Melbert BR et al (2004) Facilitative glucose transporter gene expression in human lymphocytes, monocytes and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. Blood Cells Mol Dis 32(1):182-190CrossRef
21.
go back to reference Zhao S, Kuge Y, Tsukamoto E et al (2002) Fluorodeoxyglucose uptake and glucose transporter expression in experimental inflammatory lesions and malignant tumors: effects of insulin and glucose loading. Nucl Med Commun 23:545–550PubMedCrossRef Zhao S, Kuge Y, Tsukamoto E et al (2002) Fluorodeoxyglucose uptake and glucose transporter expression in experimental inflammatory lesions and malignant tumors: effects of insulin and glucose loading. Nucl Med Commun 23:545–550PubMedCrossRef
22.
go back to reference Harik NS (2010) Management of acute hematogenous osteomyelitis in children. Expert Rev Anti Infect Ther 8(2):175-181PubMedCrossRef Harik NS (2010) Management of acute hematogenous osteomyelitis in children. Expert Rev Anti Infect Ther 8(2):175-181PubMedCrossRef
23.
go back to reference Pineda C, Vargas A, Rodriguez AV (2006) Imaging of osteomyelitis: current concepts. Infect Dis Clin N Am 20:789–825CrossRef Pineda C, Vargas A, Rodriguez AV (2006) Imaging of osteomyelitis: current concepts. Infect Dis Clin N Am 20:789–825CrossRef
24.
go back to reference Mellado Santos JM (2006) Diagnostic imaging of pediatric hematogenous osteomyelitis: lesions learned from a multi-modality approach. Eur Radiol 16:2109–2119PubMedCrossRef Mellado Santos JM (2006) Diagnostic imaging of pediatric hematogenous osteomyelitis: lesions learned from a multi-modality approach. Eur Radiol 16:2109–2119PubMedCrossRef
25.
go back to reference Ranson M (2009) Imaging of pediatric musculoskeletal Infection. Semin Musculoskelet Radiol 13:277–299PubMedCrossRef Ranson M (2009) Imaging of pediatric musculoskeletal Infection. Semin Musculoskelet Radiol 13:277–299PubMedCrossRef
26.
go back to reference Kothari NA, Pelchovitz D, Meyer J (2001) Imaging of musculoskeletal infections. Radiol Clin North Am 39:653–671PubMedCrossRef Kothari NA, Pelchovitz D, Meyer J (2001) Imaging of musculoskeletal infections. Radiol Clin North Am 39:653–671PubMedCrossRef
27.
go back to reference Oudjhane K, Arouz EM (2001) Imaging of osteomyelitis in children. Radiol Clin North Am 39:251–266PubMedCrossRef Oudjhane K, Arouz EM (2001) Imaging of osteomyelitis in children. Radiol Clin North Am 39:251–266PubMedCrossRef
28.
go back to reference Nadel H, Stillwell ME (2001) Nuclear medicine topics in pediatric musculoskeletal disease: techniques and applications. Radiol Clin North Am 39:619–651PubMedCrossRef Nadel H, Stillwell ME (2001) Nuclear medicine topics in pediatric musculoskeletal disease: techniques and applications. Radiol Clin North Am 39:619–651PubMedCrossRef
29.
go back to reference Pruthi S, Thapa M (2009) Infectious and inflammatory disorders. Magn Reson Imaging Clin N Am 17:423–438PubMedCrossRef Pruthi S, Thapa M (2009) Infectious and inflammatory disorders. Magn Reson Imaging Clin N Am 17:423–438PubMedCrossRef
30.
go back to reference Pineda C, Espinosa R, Pena A (2009) Radiologic imaging of osteomyelitis: The role of plain radiography, computed tomography, ultrasonography, magnetic resonance imaging and scintigraphy. Semin Plast Surg 23(2):80-89CrossRef Pineda C, Espinosa R, Pena A (2009) Radiologic imaging of osteomyelitis: The role of plain radiography, computed tomography, ultrasonography, magnetic resonance imaging and scintigraphy. Semin Plast Surg 23(2):80-89CrossRef
31.
go back to reference Guhlmann A, Brecht-Krauss D, Suger G et al (1998) Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings. Radiology 206:749–754PubMed Guhlmann A, Brecht-Krauss D, Suger G et al (1998) Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings. Radiology 206:749–754PubMed
32.
go back to reference Meller J, Koster G, Liersch T et al (2002) Chronic bacterial ostermyelitis: prospective comparison of (18)F-FDG imaging with a dual-head coincidence camera and (111) In-labelled autologous leukocyte scintigraphy. Eur J Nucl Med Mol Imaging 29:53–60PubMedCrossRef Meller J, Koster G, Liersch T et al (2002) Chronic bacterial ostermyelitis: prospective comparison of (18)F-FDG imaging with a dual-head coincidence camera and (111) In-labelled autologous leukocyte scintigraphy. Eur J Nucl Med Mol Imaging 29:53–60PubMedCrossRef
33.
go back to reference de Winter F, van de Wiele C, Wogelaers D et al (2001) Fluorine-18-fluoro-deoxyglucose-positron emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections. J Bone Joint Surg Am 83-A(5):651-660 de Winter F, van de Wiele C, Wogelaers D et al (2001) Fluorine-18-fluoro-deoxyglucose-positron emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections. J Bone Joint Surg Am 83-A(5):651-660
34.
go back to reference Petersdorf RG, Beeson PB (1961) Fever of unexplained origin: report on 100 cases. Medicine 40:1–30PubMedCrossRef Petersdorf RG, Beeson PB (1961) Fever of unexplained origin: report on 100 cases. Medicine 40:1–30PubMedCrossRef
35.
go back to reference de Klejin EM, Vanderbroucke JP, van der Meer JW (1997) Fever of unknown origin (FUO). I A. prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group. Medicine 76:392–400CrossRef de Klejin EM, Vanderbroucke JP, van der Meer JW (1997) Fever of unknown origin (FUO). I A. prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group. Medicine 76:392–400CrossRef
36.
go back to reference de Klejin EM, Vanderbroucke JP, van der Meer JW (1997) Fever of unknown origin (FUO). II: diagnostic procedures in a prospective multicenter study of 167 patients. The Netherlands FUO Study Group. Medicine 76:401–414CrossRef de Klejin EM, Vanderbroucke JP, van der Meer JW (1997) Fever of unknown origin (FUO). II: diagnostic procedures in a prospective multicenter study of 167 patients. The Netherlands FUO Study Group. Medicine 76:401–414CrossRef
37.
go back to reference Marcondes Machado B, Morais Cardosa D, de Paulis M et al (2009) Fever without source: evaluation of a guideline. J Pediatr (Rio J) 85:426–432 Marcondes Machado B, Morais Cardosa D, de Paulis M et al (2009) Fever without source: evaluation of a guideline. J Pediatr (Rio J) 85:426–432
38.
go back to reference Mourad O, Palda V, Detsky A (2003) A comprehensive evidence-based approach to fever of unknown origin. Arch Intern Med 163:545–551PubMedCrossRef Mourad O, Palda V, Detsky A (2003) A comprehensive evidence-based approach to fever of unknown origin. Arch Intern Med 163:545–551PubMedCrossRef
39.
go back to reference Tolan RW Jr (2010) Fever of unknown origin: a diagnostic approach to this vexing problem. Clin Pediatr 49:207–213CrossRef Tolan RW Jr (2010) Fever of unknown origin: a diagnostic approach to this vexing problem. Clin Pediatr 49:207–213CrossRef
40.
go back to reference Ishimine P (2007) The evolving approach to the young child who has fever and no obvious source. Emerg Med Clin N Am 25:1087–1115CrossRef Ishimine P (2007) The evolving approach to the young child who has fever and no obvious source. Emerg Med Clin N Am 25:1087–1115CrossRef
41.
go back to reference Steele RW, Jones SM, Lowe BA et al (1991) Usefulness of scanning procedures for diagnosis of fever of unknown origin in children. J Pediatr 119:526–530PubMedCrossRef Steele RW, Jones SM, Lowe BA et al (1991) Usefulness of scanning procedures for diagnosis of fever of unknown origin in children. J Pediatr 119:526–530PubMedCrossRef
42.
go back to reference Buonomo C, Treves ST (1993) Gallium scanning in children with fever of unknown origin. Pediatr Radiol 23:307–310PubMedCrossRef Buonomo C, Treves ST (1993) Gallium scanning in children with fever of unknown origin. Pediatr Radiol 23:307–310PubMedCrossRef
43.
go back to reference Seshadri N, Solanki CK, Balan K (2008) Utility of 111 In-labelled leukocyte scanning in patients with fever of unknown origin in an era of changing disease spectrum and investigational techniques. Nucl Med Commun 29:277–282PubMedCrossRef Seshadri N, Solanki CK, Balan K (2008) Utility of 111 In-labelled leukocyte scanning in patients with fever of unknown origin in an era of changing disease spectrum and investigational techniques. Nucl Med Commun 29:277–282PubMedCrossRef
44.
go back to reference Bar-Shalom R, Yefremov N, Guralnik L et al (2006) SPECT/CT using 67 Galium and 111Indium labeled leukocyte scintigraphy for diagnosis of infection. J Nucl Med 47:587–594PubMed Bar-Shalom R, Yefremov N, Guralnik L et al (2006) SPECT/CT using 67 Galium and 111Indium labeled leukocyte scintigraphy for diagnosis of infection. J Nucl Med 47:587–594PubMed
45.
go back to reference Meller J, Co S, Scheel AK (2007) 18 F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med 48:38–45 Meller J, Co S, Scheel AK (2007) 18 F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med 48:38–45
46.
go back to reference Ferda J, Ferdova E, Zahlava J et al (2010) Fever of unknown origin: a value of (18)F-FDG-PET/CT with integrated full diagnostic isotropic CT imaging. Eur J Radiol 73:518–525PubMedCrossRef Ferda J, Ferdova E, Zahlava J et al (2010) Fever of unknown origin: a value of (18)F-FDG-PET/CT with integrated full diagnostic isotropic CT imaging. Eur J Radiol 73:518–525PubMedCrossRef
Metadata
Title
Functional imaging of infection: conventional nuclear medicine agents and the expanding role of 18-F-FDG PET
Author
Marguerite T. Parisi
Publication date
01-07-2011
Publisher
Springer-Verlag
Published in
Pediatric Radiology / Issue 7/2011
Print ISSN: 0301-0449
Electronic ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-011-2013-7

Other articles of this Issue 7/2011

Pediatric Radiology 7/2011 Go to the issue